DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/b4hvw3/uk_ankylosing) has announced the addition of the "UK Ankylosing Spondylitis Market Highlights - 2014" report to their offering.
The latest research, 'UK Ankylosing Spondylitis Market Highlights - 2014', provides UK ankylosing spondylitis market analysis, competitive landscape, and ankylosing spondylitis drug sales forecast in UK.
The research includes UK ankylosing spondylitis market size estimates for 2013, market share forecast for six years to 2019, ankylosing spondylitis drugs market share, ankylosing spondylitis drugs sales estimates, ankylosing spondylitis drugs sales forecast, and ankylosing spondylitis late stage pipeline products.
This research helps executives track competitor drugs sales and market share in UK ankylosing spondylitis market. It supports decision making in R&D to long term marketing strategies. The report can be used for evaluating business opportunities, formulating business development strategies, and product positioning in the UK ankylosing spondylitis market.
SCOPE OF THE REPORT
- Identify drugs marketed in UK for treating ankylosing spondylitis including trade name, molecule name, company, and year of launch.
- Find out estimates for UK ankylosing spondylitis market size in 2013, key products and their sales, and how the market and products advanced from 2010. You will benefit from our accurate country and indication level valuation of products and the market.
- You will know the market share of leading ankylosing spondylitis brands in UK, including generics share.
- Find out pipeline products in clinical trial phase 3 and phase 2 for the treatment of ankylosing spondylitis. Our coverage includes molecule, mechanism of action, and the originator.
- Gain insights into how UK ankylosing spondylitis market will advance along with market forecast till 2019. Determine future market events and trends including launch of new drugs and generic erosion of leading molecules.
- Find out how ankylosing spondylitis drugs will be positioned in UK in 2019, with drug sales forecast and drug market share analysis for both marketed products and pipeline products.
Highlights of the Research:
- Marketed Ankylosing Spondylitis Drugs in UK
- UK Ankylosing Spondylitis Market Analysis
- Ankylosing Spondylitis Drugs Sales Analysis in UK
- Competitive Landscape in UK Ankylosing Spondylitis market
- Ankylosing Spondylitis Late Stage Pipeline
- UK Ankylosing Spondylitis Market Forecast
- Ankylosing Spondylitis Drugs Sales Forecast in UK
Future Competitive Landscape
For more information visit http://www.researchandmarkets.com/research/b4hvw3/uk_ankylosing